Growth Metrics

Northwest Biotherapeutics (NWBO) Long-Term Debt Repayments (2017 - 2025)

Northwest Biotherapeutics' Long-Term Debt Repayments history spans 13 years, with the latest figure at $475000.0 for Q3 2025.

  • Quarterly results put Long-Term Debt Repayments at $475000.0 for Q3 2025, down 13.79% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (down 2.6% YoY), and the annual figure for FY2025 was $1.0 million, down 8.92%.
  • Long-Term Debt Repayments for Q3 2025 was $475000.0 at Northwest Biotherapeutics, up from $465000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $4.0 million in Q1 2022 to a low of $2000.0 in Q3 2023.
  • The 5-year median for Long-Term Debt Repayments is $310000.0 (2024), against an average of $849266.7.
  • The sharpest move saw Long-Term Debt Repayments tumbled 98.0% in 2023, then surged 27450.0% in 2024.
  • Year by year, Long-Term Debt Repayments stood at $3.8 million in 2021, then tumbled by 97.41% to $99000.0 in 2022, then surged by 76.77% to $175000.0 in 2023, then skyrocketed by 77.14% to $310000.0 in 2024, then skyrocketed by 53.23% to $475000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $475000.0, $465000.0, and $71000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.